Tokyo Tape
Sign in
← Euglena

Quarterly report · Q1

2931.TEDINET S100TEIG
Period2024-01-01 → 2024-03-31
Filed2024-05-13
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥11.2bn2024-01-01 → 2024-03-31Cons.Net sales
Revenue¥46.5bn2023-01-01 → 2023-12-31Cons.Net sales (5-year summary)
Revenue¥10.8bn2023-01-01 → 2023-03-31Cons.Net sales
Operating income¥302m2024-01-01 → 2024-03-31Cons.Operating income
Operating income−¥176m2023-01-01 → 2023-03-31Cons.Operating income
Ordinary income¥266m2024-01-01 → 2024-03-31Cons.Ordinary income
Ordinary income−¥1.4bn2023-01-01 → 2023-12-31Cons.Ordinary income loss (5-year summary)
Ordinary income−¥111m2023-01-01 → 2023-03-31Cons.Ordinary income
Profit before tax−¥216m2024-01-01 → 2024-03-31Cons.Income before income taxes
Profit before tax−¥81m2023-01-01 → 2023-03-31Cons.Income before income taxes
Net income (owners)¥191m2024-01-01 → 2024-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)−¥2.7bn2023-01-01 → 2023-12-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥167m2023-01-01 → 2023-03-31Cons.Profit loss attributable to owners of parent
Net income¥191m2024-01-01 → 2024-03-31Cons.Profit loss
Net income−¥168m2023-01-01 → 2023-03-31Cons.Profit loss
Total assets¥71.2bnat 2024-03-31Cons.Assets
Total assets¥59.6bnat 2023-12-31Cons.Assets
Total assets¥63.3bnat 2023-03-31Cons.Total assets (5-year summary)
Total liabilities¥40.3bnat 2024-03-31Cons.Liabilities
Total liabilities¥39.4bnat 2023-12-31Cons.Liabilities
Net assets / equity¥30.9bnat 2024-03-31Cons.Net assets
Net assets / equity¥20.2bnat 2023-12-31Cons.Net assets
Net assets / equity¥22.5bnat 2023-03-31Cons.Net assets (5-year summary)
Cash and deposits¥18.9bnat 2024-03-31Cons.Cash and deposits
Cash and deposits¥15.8bnat 2023-12-31Cons.Cash and deposits
EPS (basic)¥1.492024-01-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-22.762023-01-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-1.462023-01-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
Equity ratio43.4%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio33.9%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio35.5%at 2023-03-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 26
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-03-31−¥392m
jpcrp040300-q1r_E27054-000Biofuel Businessreportable segmentrevenue2024-01-01 → 2024-03-31¥118m
jpcrp040300-q1r_E27054-000Biofuel Businessreportable segmentrevenue external2024-01-01 → 2024-03-31¥118m
jpcrp040300-q1r_E27054-000Biofuel Businessreportable segmentsegment profit2024-01-01 → 2024-03-31−¥126m
jpcrp040300-q1r_E27054-000Health Care Businessreportable segmentrevenue2024-01-01 → 2024-03-31¥10.3bn
jpcrp040300-q1r_E27054-000Health Care Businessreportable segmentrevenue external2024-01-01 → 2024-03-31¥10.3bn
jpcrp040300-q1r_E27054-000Health Care Businessreportable segmentsegment profit2024-01-01 → 2024-03-31¥922m
jpcrp040300-q1r_E27054-000Others Businessreportable segmentrevenue2024-01-01 → 2024-03-31¥732m
jpcrp040300-q1r_E27054-000Others Businessreportable segmentrevenue external2024-01-01 → 2024-03-31¥732m
jpcrp040300-q1r_E27054-000Others Businessreportable segmentsegment profit2024-01-01 → 2024-03-31−¥101m
Total Of Reportable Segments And Otherssegment totalrevenue2024-01-01 → 2024-03-31¥11.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-01-01 → 2024-03-31¥11.2bn
Total Of Reportable Segments And Otherssegment totalsegment profit2024-01-01 → 2024-03-31¥694m
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-03-31−¥425m
jpcrp040300-q1r_E27054-000Biofuel Businessreportable segmentrevenue2023-01-01 → 2023-03-31¥52m
jpcrp040300-q1r_E27054-000Biofuel Businessreportable segmentrevenue external2023-01-01 → 2023-03-31¥52m
jpcrp040300-q1r_E27054-000Biofuel Businessreportable segmentsegment profit2023-01-01 → 2023-03-31−¥227m
jpcrp040300-q1r_E27054-000Health Care Businessreportable segmentrevenue2023-01-01 → 2023-03-31¥10.0bn
jpcrp040300-q1r_E27054-000Health Care Businessreportable segmentrevenue external2023-01-01 → 2023-03-31¥10.0bn
jpcrp040300-q1r_E27054-000Health Care Businessreportable segmentsegment profit2023-01-01 → 2023-03-31¥572m
jpcrp040300-q1r_E27054-000Others Businessreportable segmentrevenue2023-01-01 → 2023-03-31¥758m
jpcrp040300-q1r_E27054-000Others Businessreportable segmentrevenue external2023-01-01 → 2023-03-31¥758m
jpcrp040300-q1r_E27054-000Others Businessreportable segmentsegment profit2023-01-01 → 2023-03-31−¥95m
Total Of Reportable Segments And Otherssegment totalrevenue2023-01-01 → 2023-03-31¥10.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-01-01 → 2023-03-31¥10.8bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-01-01 → 2023-03-31¥249m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 455
ItemContextValueUnit
Capital stockPrior1YearInstant15867000000JPY
Capital stockCurrentQuarterInstant15867000000JPY
Capital surplusPrior1YearInstant15198000000JPY
Capital surplusCurrentQuarterInstant16418000000JPY
Retained earningsPrior1YearInstant-10961000000JPY
Retained earningsCurrentQuarterInstant-1426000000JPY
Treasury stockPrior1YearInstant-34000000JPY
Treasury stockCurrentQuarterInstant-34000000JPY
Shareholders equityPrior1YearInstant20070000000JPY
Shareholders equityCurrentQuarterInstant30825000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant138000000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant76000000JPY
Deferred gains or losses on hedgesPrior1YearInstant1000000JPY
Deferred gains or losses on hedgesCurrentQuarterInstant-0JPY
Foreign currency translation adjustmentPrior1YearInstant1000000JPY
Foreign currency translation adjustmentCurrentQuarterInstant-6000000JPY
Remeasurements of defined benefit plansPrior1YearInstant1000000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant1000000JPY
Valuation and translation adjustmentsPrior1YearInstant142000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant70000000JPY
Subscription rights to sharesPrior1YearInstant1000000JPY
Subscription rights to sharesCurrentQuarterInstant1000000JPY
Net assetsPrior1YearInstant20214000000JPY
Net assetsCurrentQuarterInstant30897000000JPY
Liabilities and net assetsPrior1YearInstant59619000000JPY
Liabilities and net assetsCurrentQuarterInstant71161000000JPY
Net salesPrior1YTDDuration10837000000JPY
Net salesCurrentYTDDuration11154000000JPY
Cost of salesPrior1YTDDuration2996000000JPY
Cost of salesCurrentYTDDuration3130000000JPY
Gross profitPrior1YTDDuration7841000000JPY
Gross profitCurrentYTDDuration8024000000JPY
Selling general and administrative expensesPrior1YTDDuration8017000000JPY
Selling general and administrative expensesCurrentYTDDuration7721000000JPY
Operating incomePrior1YTDDuration-176000000JPY
Operating incomeCurrentYTDDuration302000000JPY
Interest income noiPrior1YTDDuration1000000JPY
Interest income noiCurrentYTDDuration2000000JPY
Foreign exchange gains noiPrior1YTDDuration3000000JPY
Foreign exchange gains noiCurrentYTDDuration52000000JPY
Subsidy income noi bountyPrior1YTDDuration188000000JPY
Subsidy income noi bountyCurrentYTDDuration23000000JPY
Commission fee noiPrior1YTDDuration10000000JPY
Commission fee noiCurrentYTDDuration0JPY
Equity in earnings of affiliates noiPrior1YTDDuration－JPY
Equity in earnings of affiliates noiCurrentYTDDuration9000000JPY
Other noiPrior1YTDDuration39000000JPY
Other noiCurrentYTDDuration21000000JPY
Non operating incomePrior1YTDDuration242000000JPY
Non operating incomeCurrentYTDDuration110000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-12-31pass rounding
balance sheet identityconsolidated 2024-03-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-03-31pass
statement vs summary · net income attributable to parentconsolidated 2024-01-01/2024-03-31pass
statement vs summary · revenueconsolidated 2023-01-01/2023-03-31pass
statement vs summary · revenueconsolidated 2024-01-01/2024-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass
statement vs summary · total assetsconsolidated 2024-03-31pass